» Authors » Smriti Kundu-Raychaudhuri

Smriti Kundu-Raychaudhuri

Explore the profile of Smriti Kundu-Raychaudhuri including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 184
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Raychaudhuri S, Abria C, Harmany Z, Smith C, Kundu-Raychaudhuri S, Raychaudhuri S, et al.
Int J Rheum Dis . 2019 Oct; 22(12):2165-2169. PMID: 31659868
Purpose: To assess the capability of in vivo positron emission tomography (PET) using F-fluorodeoxyglucose ( F-FDG) to quantify changes in inflammatory activity in response to tofacitinib, a Janus kinase (JAK)...
2.
Kundu-Raychaudhuri S, Abria C, Raychaudhuri S
Cytokine . 2016 Jan; 79:45-51. PMID: 26751012
Objective: The regulatory role of the Th9 cells along with its signature cytokine IL-9 in human immune system and its aberrant activation in autoimmune diseases is currently under investigation. We...
3.
Mitra A, Luna J, Marusina A, Merleev A, Kundu-Raychaudhuri S, Fiorentino D, et al.
J Invest Dermatol . 2015 Jul; 135(11):2873-2876. PMID: 26134944
No abstract available.
4.
Datta-Mitra A, Kundu-Raychaudhuri S, Mitra A, Raychaudhuri S
PLoS One . 2015 Apr; 10(4):e0121626. PMID: 25876154
Background: Increasing evidence points to a role for the extra-neuronal nerve growth factor (NGF) in acquired immune responses. However, very little information is available about its role and underlying mechanism...
5.
Kundu-Raychaudhuri S, Chen Y, Wulff H, Raychaudhuri S
J Autoimmun . 2014 Sep; 55:63-72. PMID: 25175978
Kv1.3 channels regulate the activation/proliferation of effector memory T cells and thus play a critical role in the pathogenesis of autoimmune diseases. Using a combination of immunohistochemistry, confocal microscopy, flow...
6.
Kundu-Raychaudhuri S, Mitra A, Datta-Mitra A, Chaudhari A, Raychaudhuri S
Int J Rheum Dis . 2014 Jun; 19(5):452-8. PMID: 24965561
Aim: To quantify the progression and severity of mouse collagen-induced arthritis (CIA) using an in vivo imaging tool, (18) F-fluorodeoxyglucose ((18) F-FDG) PET/CT and validate it against gold standard 'histopathological'...
7.
Kundu-Raychaudhuri S, Datta-Mitra A, Abria C, Peters J, Raychaudhuri S
Indian J Dermatol Venereol Leprol . 2014 May; 80(3):204-13. PMID: 24823397
Psoriasis is a multifactorial chronic inflammatory disease. Research into the pathogenesis of this disease is hindered by the lack of a proper animal model. Over the past two decades, many...
8.
Datta-Mitra A, Mitra A, Ray R, Raychaudhuri S, Kundu-Raychaudhuri S
Int Immunopharmacol . 2013 Sep; 17(3):744-51. PMID: 24036370
Purpose: The molecular mechanism responsible for the immunomodulatory effect of 1,25-dihydroxyvitamin D3 (Vit-D) is still not well elucidated. Unavoidable systemic toxicity of Vit-D has encouraged to develop more potent and...
9.
Mitra A, Raychaudhuri S, Abria C, Mitra A, Wright R, Ray R, et al.
J Invest Dermatol . 2013 Jan; 133(6):1556-64. PMID: 23314787
The efficacy of 1α,25-dihydroxyvitamin D3 (Vit-D) limits its topical use despite its profound effects on cellular differentiation, proliferation, and immunomodulation. Therefore, in search for a more effective analog of Vit-D,...
10.
Raychaudhuri S, Kundu-Raychaudhuri S, Tamura K, Masunaga T, Kubo K, Hanaoka K, et al.
J Invest Dermatol . 2008 Mar; 128(8):1969-76. PMID: 18337836
In psoriasis, CD28/B7 costimulatory molecules are well characterized. Here, using the severe combined immunodeficient (SCID) mouse-psoriasis xenograft model, we report therapeutic efficacy of a humanized anti-CD28 monoclonal antibody (FR255734; Astellas...